Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy.

Rossignoli F, Grisendi G, Spano C, Golinelli G, Recchia A, Rovesti G, Orsi G, Veronesi E, Horwitz EM, Dominici M.

Cancer Gene Ther. 2018 Jun 29. doi: 10.1038/s41417-018-0034-1. [Epub ahead of print]

PMID:
29955091
2.

Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro.

Checchi M, Bertacchini J, Grisendi G, Smargiassi A, Sola A, Messori M, Palumbo C.

Biomedicines. 2017 Dec 25;6(1). pii: E3. doi: 10.3390/biomedicines6010003.

3.

Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression.

Baglio SR, Lagerweij T, Pérez-Lanzón M, Ho XD, Léveillé N, Melo SA, Cleton-Jansen AM, Jordanova ES, Roncuzzi L, Greco M, van Eijndhoven MAJ, Grisendi G, Dominici M, Bonafede R, Lougheed SM, de Gruijl TD, Zini N, Cervo S, Steffan A, Canzonieri V, Martson A, Maasalu K, Köks S, Wurdinger T, Baldini N, Pegtel DM.

Clin Cancer Res. 2017 Jul 15;23(14):3721-3733. doi: 10.1158/1078-0432.CCR-16-2726. Epub 2017 Jan 4. Erratum in: Clin Cancer Res. 2018 Feb 1;24(3):724.

PMID:
28053020
4.

Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.

Petrachi T, Romagnani A, Albini A, Longo C, Argenziano G, Grisendi G, Dominici M, Ciarrocchi A, Dallaglio K.

Oncotarget. 2017 Jan 24;8(4):6914-6928. doi: 10.18632/oncotarget.14321.

5.

In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.

Latella MC, Di Salvo MT, Cocchiarella F, Benati D, Grisendi G, Comitato A, Marigo V, Recchia A.

Mol Ther Nucleic Acids. 2016 Nov 22;5(11):e389. doi: 10.1038/mtna.2016.92.

6.

Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Conforti A, Starc N, Biagini S, Tomao L, Pitisci A, Algeri M, Sirleto P, Novelli A, Grisendi G, Candini O, Carella C, Dominici M, Locatelli F, Bernardo ME.

Oncotarget. 2016 Nov 22;7(47):77416-77429. doi: 10.18632/oncotarget.12678.

7.

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.

Fiorcari S, Maffei R, Audrito V, Martinelli S, Ten Hacken E, Zucchini P, Grisendi G, Potenza L, Luppi M, Burger JA, Deaglio S, Marasca R.

Oncotarget. 2016 Oct 4;7(40):65968-65981. doi: 10.18632/oncotarget.11782.

8.

Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.

Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N, Kusuzaki K, Chano T, Grisendi G, Dominici M, De Milito A, Baldini N.

Oncotarget. 2016 Sep 27;7(39):63408-63423. doi: 10.18632/oncotarget.11503.

9.

TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.

Guiho R, Biteau K, Grisendi G, Taurelle J, Chatelais M, Gantier M, Heymann D, Dominici M, Redini F.

Int J Cancer. 2016 Dec 15;139(12):2802-2811. doi: 10.1002/ijc.30402. Epub 2016 Sep 12.

10.

CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.

Saltari A, Truzzi F, Quadri M, Lotti R, Palazzo E, Grisendi G, Tiso N, Marconi A, Pincelli C.

J Invest Dermatol. 2016 Oct;136(10):2049-2058. doi: 10.1016/j.jid.2016.05.116. Epub 2016 Jun 18.

11.

Tumor Stroma Manipulation By MSC.

Grisendi G, Spano C, Rossignoli F, D Souza N, Golinelli G, Fiori A, Horwitz EM, Guarneri V, Piacentini F, Paolucci P, Dominici M.

Curr Drug Targets. 2016;17(10):1111-26. Review.

PMID:
26953248
12.

Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.

Perut F, Carta F, Bonuccelli G, Grisendi G, Di Pompo G, Avnet S, Sbrana FV, Hosogi S, Dominici M, Kusuzaki K, Supuran CT, Baldini N.

Expert Opin Ther Targets. 2015;19(12):1593-605. doi: 10.1517/14728222.2016.1086339. Epub 2015 Sep 10.

PMID:
26357839
13.

A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.

Prapa M, Caldrer S, Spano C, Bestagno M, Golinelli G, Grisendi G, Petrachi T, Conte P, Horwitz EM, Campana D, Paolucci P, Dominici M.

Oncotarget. 2015 Sep 22;6(28):24884-94. doi: 10.18632/oncotarget.4670.

14.

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.

D'souza N, Rossignoli F, Golinelli G, Grisendi G, Spano C, Candini O, Osturu S, Catani F, Paolucci P, Horwitz EM, Dominici M.

BMC Med. 2015 Aug 12;13:186. doi: 10.1186/s12916-015-0426-0. Review.

15.

Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.

Ferrari-Amorotti G, Chiodoni C, Shen F, Cattelani S, Soliera AR, Manzotti G, Grisendi G, Dominici M, Rivasi F, Colombo MP, Fatatis A, Calabretta B.

Neoplasia. 2014 Dec;16(12):1047-58. doi: 10.1016/j.neo.2014.10.006.

16.

Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis.

Candini O, Spano C, Murgia A, Grisendi G, Veronesi E, Piccinno MS, Ferracin M, Negrini M, Giacobbi F, Bambi F, Horwitz EM, Conte P, Paolucci P, Dominici M.

Stem Cells. 2015 Mar;33(3):939-50. doi: 10.1002/stem.1897.

17.

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.

Grisendi G, Spano C, D'souza N, Rasini V, Veronesi E, Prapa M, Petrachi T, Piccinno S, Rossignoli F, Burns JS, Fiorcari S, Granchi D, Baldini N, Horwitz EM, Guarneri V, Conte P, Paolucci P, Dominici M.

Stem Cells. 2015 Mar;33(3):859-69. doi: 10.1002/stem.1903.

18.

Detection of microparticles from human red blood cells by multiparametric flow cytometry.

Grisendi G, Finetti E, Manganaro D, Cordova N, Montagnani G, Spano C, Prapa M, Guarneri V, Otsuru S, Horwitz EM, Mari G, Dominici M.

Blood Transfus. 2015 Apr;13(2):274-80. doi: 10.2450/2014.0136-14. Epub 2014 Oct 23.

19.

CD271 mediates stem cells to early progeny transition in human epidermis.

Truzzi F, Saltari A, Palazzo E, Lotti R, Petrachi T, Dallaglio K, Gemelli C, Grisendi G, Dominici M, Pincelli C, Marconi A.

J Invest Dermatol. 2015 Mar;135(3):786-795. doi: 10.1038/jid.2014.454. Epub 2014 Oct 20.

20.

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.

Bonuccelli G, Avnet S, Grisendi G, Salerno M, Granchi D, Dominici M, Kusuzaki K, Baldini N.

Oncotarget. 2014 Sep 15;5(17):7575-88.

21.

Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells.

Golinelli G, Grisendi G, Spano C, Dominici M.

Hum Gene Ther. 2014 May;25(5):406-7. doi: 10.1089/hum.2014.039. No abstract available.

22.

Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, Giordano R, Montemurro T, Bourin P, Sensebé L, Rojewski MT, Schrezenmeier H, Layrolle P, Ginebra MP, Panaitescu CB, Gómez-Barrena E, Catani F, Paolucci P, Burns JS, Dominici M.

Tissue Eng Part C Methods. 2014 Mar;20(3):239-51. doi: 10.1089/ten.TEC.2013.0250. Epub 2013 Aug 20.

23.

Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance.

Piccinno MS, Veronesi E, Loschi P, Pignatti M, Murgia A, Grisendi G, Castelli I, Bernabei D, Candini O, Conte P, Paolucci P, Horwitz EM, De Santis G, Iughetti L, Dominici M.

Apoptosis. 2013 Oct;18(10):1274-89. doi: 10.1007/s10495-013-0878-7.

24.

IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.

Caselli A, Olson TS, Otsuru S, Chen X, Hofmann TJ, Nah HD, Grisendi G, Paolucci P, Dominici M, Horwitz EM.

Stem Cells. 2013 Oct;31(10):2193-204. doi: 10.1002/stem.1463.

25.

Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood.

Rossignoli F, Caselli A, Grisendi G, Piccinno S, Burns JS, Murgia A, Veronesi E, Loschi P, Masini C, Conte P, Paolucci P, Horwiz EM, Dominici M.

Biomed Res Int. 2013;2013:901821. doi: 10.1155/2013/901821. Epub 2013 Mar 31.

26.

Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion.

Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, Manzotti G, Grisendi G, Dominici M, Pieraccioli M, Raschellà G, Chiodoni C, Colombo MP, Calabretta B.

Cancer Res. 2013 Jan 1;73(1):235-45. doi: 10.1158/0008-5472.CAN-12-1739. Epub 2012 Oct 10.

27.

MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential.

D'souza N, Burns JS, Grisendi G, Candini O, Veronesi E, Piccinno S, Horwitz EM, Paolucci P, Conte P, Dominici M.

Adv Biochem Eng Biotechnol. 2013;130:209-66. doi: 10.1007/10_2012_150.

PMID:
22990585
28.

IFN-β expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling.

Tamassia N, Bazzoni F, Le Moigne V, Calzetti F, Masala C, Grisendi G, Bussmeyer U, Scutera S, De Gironcoli M, Costantini C, Musso T, Cassatella MA.

J Immunol. 2012 Aug 1;189(3):1500-9. doi: 10.4049/jimmunol.1102985. Epub 2012 Jun 22.

29.

Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy.

Burns JS, Safwat A, Grisendi G, Kassem M, Dominici M.

Cancer Lett. 2012 Dec 1;325(1):1-10. doi: 10.1016/j.canlet.2012.05.027. Epub 2012 May 29. Review.

PMID:
22659735
30.

Combination of low doses of enzastaurin and lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines.

Cosenza M, Civallero M, Grisendi G, Marcheselli L, Roat E, Bari A, Sacchi S.

Ann Hematol. 2012 Oct;91(10):1613-22. doi: 10.1007/s00277-012-1490-6. Epub 2012 May 24.

PMID:
22623160
31.

In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.

Ciavarella S, Grisendi G, Dominici M, Tucci M, Brunetti O, Dammacco F, Silvestris F.

Br J Haematol. 2012 Jun;157(5):586-98. doi: 10.1111/j.1365-2141.2012.09082.x. Epub 2012 Mar 16.

PMID:
22420897
32.

Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.

Fragliasso V, Chiodo Y, Ferrari-Amorotti G, Soliera AR, Manzotti G, Cattelani S, Candini O, Grisendi G, Vergalli J, Mariani SA, Guerzoni C, Calabretta B.

J Cell Biochem. 2012 May;113(5):1704-13. doi: 10.1002/jcb.24040.

33.

Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.

Grisendi G, Bussolari R, Veronesi E, Piccinno S, Burns JS, De Santis G, Loschi P, Pignatti M, Di Benedetto F, Ballarin R, Di Gregorio C, Guarneri V, Piccinini L, Horwitz EM, Paolucci P, Conte P, Dominici M.

Am J Cancer Res. 2011;1(6):787-805. Epub 2011 May 28.

34.

Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro.

Barti-Juhasz H, Mihalik R, Nagy K, Grisendi G, Dominici M, Petak I.

Haematologica. 2011 Mar;96(3):e21-2. doi: 10.3324/haematol.2010.036822. No abstract available.

35.

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.

Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E, De Santis G, Spano C, Tagliazzucchi M, Barti-Juhasz H, Scarabelli L, Bambi F, Frassoldati A, Rossi G, Casali C, Morandi U, Horwitz EM, Paolucci P, Conte P, Dominici M.

Cancer Res. 2010 May 1;70(9):3718-29. doi: 10.1158/0008-5472.CAN-09-1865. Epub 2010 Apr 13.

36.

GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.

Grisendi G, Annerén C, Cafarelli L, Sternieri R, Veronesi E, Cervo GL, Luminari S, Maur M, Frassoldati A, Palazzi G, Otsuru S, Bambi F, Paolucci P, Pierfranco C, Horwitz E, Dominici M.

Cytotherapy. 2010 Jul;12(4):466-77. doi: 10.3109/14653241003649510.

PMID:
20353309
37.

Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines.

Civallero M, Cosenza M, Grisendi G, Marcheselli L, Todoerti K, Sacchi S.

Leuk Lymphoma. 2010 Apr;51(4):671-9. doi: 10.3109/10428191003637290.

PMID:
20218811

Supplemental Content

Loading ...
Support Center